TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Reduction of post-stroke ULS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of cataract surgery
Endpoint domain: Mortality/survival
Primary endpoint: Skin temperature retention rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: SF-36 Physical Component Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Verbal rating scores for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tracheal extubation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: discharge time from the intensive care unit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rates of complications associated with constipation or diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1 year %EWL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: new-onset atrial fibrillation (AF)
Endpoint domain: Mortality/survival
Primary endpoint: treatment-emergent dizziness
Endpoint domain: Adverse events/effects
Primary endpoint: positive orthostatic test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Natural deliveries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Induced deliveries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Mean Major Symptom Score (MSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-assessed quality of life (SNOT-20 GAV)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Composite outcome of major bleeding and clinically relevant nonmajor bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Subcutaneous fat layer thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Circumference of thighs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: posttreatment hearing gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean logins to the library
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of Full‐Serve participants utilizing the service
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: severity of behavioral problems after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean percent change of VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: THI improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SD long-term effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean p50 increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: servings of fruit and vegetables
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: behavioral measure of fat consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total death and myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: satisfaction with physicians’ disclosure of results
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: learning accurate disease risk information
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: long-term score increases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: long-term learning efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean alanine transaminase (ALT) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Mean hepatitis B virus (HBV)-DNA load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Psychologic domain of HRQOL
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Physical domain score of HRQOL
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Joint space measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean LDL cholesterol level decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Control of pelvic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hospitalization for cardiovascular reasons
Endpoint domain: Mortality/survival
Primary endpoint: day of discharge
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: side effect profile
Endpoint domain: Adverse events/effects
Primary endpoint: Mean time to treatment failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biopsy-proven acute rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of gastrointestinal disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Median response duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Vasopressor requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Expiratory strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in depressive symptomatology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronic pain rate after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to pain disappearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of atopic dermatitis (AD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement in forced expiratory volume at 1 second
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Fewer asthma exacerbations up to day 7
Endpoint domain: Adverse events/effects
Primary endpoint: Contrast nephropathy (CN) development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Type of dyschromatopsia at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Testosterone (TT) concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Sex Hormone-Binding Globulin (SHBG) concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Quality of life according to AMS scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cumulative girth loss after 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Statistically significant cosmetic improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Lp (a) concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in glomerular filtration rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: maximal percentage decrease in FEV1 after exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: percentage protection against exercise-induced bronchoconstriction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Early clinical response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shortened treatment course
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean residual volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with hiccups completely stopped
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean low-density lipoprotein cholesterol decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Response/remission determined by Crohn's disease activity index after 1 month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of dysuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of dysuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normalization of dysuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of VAS scores for postoperative pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global verbal pain rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to first dose of analgesic medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of invasive prostate cancer (PCa)
Endpoint domain: Mortality/survival
Primary endpoint: Adverse reactions to fined wine
Endpoint domain: Adverse events/effects
Primary endpoint: Time to fall asleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Number of awakenings after sleep onset
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Incidence of patients who were emesis-free 24 hours after anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pregnancy rates per embryo transfer (PRs per ET)
Endpoint domain: Mortality/survival
Primary endpoint: post-treatment ECG metrics and patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Dental anxiety levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of dementia care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Thrombus disappearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in thrombus size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: behavior score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: practical ECC performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of initial assessment algorithm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adequate introduction to BLS skills
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 100% ulcer healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ≥80% ulcer healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygen concentration at the mask
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of change in LII (Linear Intercept Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differential protein expression in PBMCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in IMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: IFA positive rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IFA GMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IFA sero-negative rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: case recall
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: prevalence of frailty
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum levels of M‐CSF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma levels of TGF‐beta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pain intensity and opioid consumption (PIOC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-SLEDAI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fatigue severity scale (FSS)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: mean change in decision-making influenced by GRADE system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct identification of the need for tuberculin skin test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete protection from nausea and vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Episodes of fever and neutropenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mean duration of neutropenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: role limitation due to physical health
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Lower urinary scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inspiratory effort reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: HIV treatment outcomes after release from prison
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival to 18 months of age
Endpoint domain: Mortality/survival
Primary endpoint: Risk of death or invasive ventilation
Endpoint domain: Mortality/survival
Primary endpoint: Daytime anti-hypertensive effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Signs of cutaneous aging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Postoperative neurologic symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Ischemia-driven revascularization
Endpoint domain: Mortality/survival
Primary endpoint: CD4/CD8 and Th1/Th2 cell ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: serum IL-2 and IFN-γ contents
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: serum IL-4 and IL-10 contents
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: de novo dyspareunia rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall postoperative sexual function scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Patient Global Impression of Improvement scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Postoperative Mini-Mental-Status scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Postoperative arterial lactate concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Probability of success-I at 9 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Probability of success-II at 9 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Advance Directive (AD) completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of oral clefts
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of major congenital malformations
Endpoint domain: Adverse events/effects
Primary endpoint: Bioavailability of gabapentin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: future intention to smoke
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Predictions of drug efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QoR-40 score at 6 hours after surgery
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Postprandial ghrelin secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Reduction in perception of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of TTV infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Growth and development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived Stress Scale (PSS) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CFS symptom frequency and severity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anastomotic leakage rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to maximum plasma concentration (C(max)) of anagrelide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart rate increase after anagrelide administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of palpitations
Endpoint domain: Adverse events/effects
Primary endpoint: Change in LS BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak plasma glucose concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: peak serum insulin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Post-endoscopy blood transfusion requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychological health measures
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction of pain measured by VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in spine mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial global photodamage success or improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emotional Arousal (EA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tension Arousal (TA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients achieving > or = 50% reduction in migraine attack frequencies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diabetes-specific quality of life (QOL) for children
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Diabetes-specific quality of life (QOL) for adolescents
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of life (QOL) for parents
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: odds of anemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Survival at 39 months
Endpoint domain: Mortality/survival
Primary endpoint: Cardiovascular data changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diagnostic contrast effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NRS rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful rescue sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Roland Morris Disability Questionnaire score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in IIQ
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Improvement in ICIQ
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cumulative recurrence rate at day 56
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mean corrected lung/plasma ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean corrected lung/plasma area under the concentration-time curve ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: remission of proteinuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Reduction of Neuropsychiatric Symptoms (NPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of Extrapyramidal Symptoms (EPS)
Endpoint domain: Adverse events/effects
Primary endpoint: Week 12 median natural log VZV antibody titer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: nausea and vomiting complaints
Endpoint domain: Adverse events/effects
Primary endpoint: median radiographic healing score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: proportion of healed ostectomies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: BPOS (Bowel Pressure Oscillation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: SOCA (Sphincter of Oddi Compliance Assessment)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Composite therapeutic failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Tubular and glomerular functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: HF-related quality of life (HFQOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: VISA-A scale improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression-free survival benefit
Endpoint domain: Mortality/survival